CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 1 filers reported holding CLOVIS ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $2,421,000 | +309.6% | 82,430 | +534.1% | 5.78% | +350.9% |
| Q2 2018 | $591,000 | -13.8% | 13,000 | 0.0% | 1.28% | -4.7% |
| Q1 2018 | $686,000 | -32.7% | 13,000 | -13.3% | 1.34% | +52.5% |
| Q4 2017 | $1,020,000 | -17.5% | 15,000 | 0.0% | 0.88% | -20.5% |
| Q3 2017 | $1,236,000 | -12.0% | 15,000 | 0.0% | 1.11% | -13.8% |
| Q2 2017 | $1,404,000 | -26.5% | 15,000 | -50.0% | 1.29% | -9.3% |
| Q1 2017 | $1,910,000 | +43.3% | 30,000 | 0.0% | 1.42% | +33.5% |
| Q4 2016 | $1,333,000 | -7.4% | 30,000 | -60.0% | 1.06% | -4.6% |
| Q1 2016 | $1,440,000 | -17.7% | 75,000 | +50.0% | 1.11% | -3.7% |
| Q4 2015 | $1,750,000 | -67.5% | 50,000 | -14.6% | 1.16% | -61.1% |
| Q3 2015 | $5,386,000 | +17.0% | 58,567 | +11.8% | 2.97% | -18.5% |
| Q2 2015 | $4,605,000 | +10.8% | 52,400 | -6.4% | 3.65% | +4.7% |
| Q1 2015 | $4,156,000 | +174.9% | 55,988 | +107.4% | 3.48% | +132.8% |
| Q4 2014 | $1,512,000 | – | 27,000 | – | 1.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 150,000 | $1,564,000 | 4.60% |
| Healthcare Value Capital, LLC | 100,000 | $1,043,000 | 3.07% |
| Palo Alto Investors LP | 5,056,286 | $52,712,000 | 2.90% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,328,200 | $13,848,000 | 1.53% |
| Ikarian Capital, LLC | 513,700 | $5,355,000 | 0.87% |
| Pinz Capital Management, LP | 207,800 | $2,166,000 | 0.79% |
| Leap Investments LP | 146,300 | $1,525,000 | 0.72% |
| Elk Creek Partners, LLC | 574,616 | $5,990,000 | 0.69% |
| SECTOR GAMMA AS | 408,625 | $4,260,000 | 0.68% |
| Artal Group S.A. | 1,000,000 | $10,425,000 | 0.40% |